icon

Back to all articles

  1. Home
    arrow-right-icon
  2. News
    arrow-right-icon
  3. GetLabTest News
    arrow-right-icon
  4. Killer Heart Disease Epidemic Sweeping UK As It Faces 'Worst Heart Care Crisis in Living Memory', Cardiologist Warns

Killer Heart Disease Epidemic Sweeping UK As It Faces 'Worst Heart Care Crisis in Living Memory', Cardiologist Warns

killer-heart-disease-epidemic-sweeping-uk-as-it-faces-worst-heart-care-crisis-in-living-memory-cardiologist-warns-post-image

For the first time in 60 years, the number of premature deaths from cardiovascular disease (CVD) in those under 75 is on the rise. The British Heart Foundation (BHF) sounded the alarm earlier this year, calling for ‘urgent' Government intervention to help stop this ‘worrying' upward trend in early CVD deaths.

The charity's figures reveal that since 2020, the number of premature CVD deaths has continued to rise year-on-year - the latest data shows that in 2022 the early death rate for CVD in England had risen to 80 in 100,000 people, the highest rate since 2011. Around one in four premature deaths in the UK is caused by CVD, the BHF states.

Dr Sonya Babu-Narayan, a Consultant Cardiologist and the BHF Associate Medical Director shared the warning as part of the charity's campaign for ‘urgent intervention' in UK heart care.

She told the BHF: ‘We're in the grip of the worst heart care crisis in living memory. Every part of the system providing heart care is damaged, from prevention, diagnosis, treatment, and recovery, to crucial research that could give us faster and better treatments.

Dr Babu-Narayan added: ‘I find it tragic that we've lost hard-won progress to reduce early death from cardiovascular disease. Furthermore, we are still seeing more people than expected die from cardiovascular conditions overall - more than any other disease group. It's clear to me that urgent intervention is long overdue.'

What is cardiovascular disease and am I at risk?
Cardiovascular disease is an umbrella term used to describe diseases of the heart or blood vessels that commonly reduce blood flow to the heart, brain, or body due to blood clots or a build-up of fatty deposits, the NHS states. The most common types of CVD are coronary heart disease, stroke, peripheral arterial disease, and aortic disease.

Risk factors for CVD are prevalent in the UK population, including high blood pressure, high cholesterol, diabetes, smoking, obesity, physical inactivity, and a family history of CVD.

What's causing the rise in CVD?
The BHF states that the rising tide of CVD can only be partially attributed to the impact of the COVID-19 pandemic and the increased pressure on the NHS. It states that ‘warning signs' have predicted a ‘significant slowdown' in the prevention of early CVD deaths since 2012. The rate fell just 11 percent in the seven years from 2012 to 2019, compared with a reduction of 33% in the previous seven-year period.

Other factors contributing to this rise include a passive governmental approach to addressing cardiovascular risk factors over the past decade, the BHF claims - with millions living with undiagnosed and unmanaged diabetes, high blood pressure, raised cholesterol, and obesity.

The disparity in healthcare for the rich and poor has also ‘significantly widened' since 2010, with those in more deprived areas seeing poorer health outcomes, the charity states. Meanwhile, NHS waiting lists for heart care continue to grow, with 75% more people on the list compared with February 2020, the BHF reports.

How can I check if I'm at risk or have CVD?
Early detection through preventive checkups and screening tests plays a crucial role in catching CVD early. Monitoring your blood pressure and having an EKG check your heart's electrical signals is a good place to start, and here are three blood tests that can help identify CVD:

  • Cholesterol panel: This measures your total cholesterol, levels of good cholesterol (HDL), bad cholesterol (non-HDL), and triglycerides in your blood.
  • Blood sugar tests: Measuring glucose levels to detect diabetes or prediabetes.
  • Inflammatory markers: Tests for inflammation, which could indicate increased CVD risk, by measuring for markers such as hs-CRP.

If you are found to have risk factors for CVD, your doctor may prescribe you medications to help manage this risk, including blood pressure or cholesterol-lowering drugs. Consider using a service like GetLabTest. They offer convenient and affordable testing options.

While not always popular, it's also important to remember that lifestyle modifications are the cornerstone of heart health. BHF research shows that regular exercise can cut your risk of heart disease by up to 35%, and recommends following the Eatwell guide for a balanced diet.

CVD is highly preventable, and 85% could be avoided by modifying risk factors the NHS states. However, it continues to pose a huge public health threat to the UK and the BHF suggests that weak public health policies are failing to control the rising tide. Rightly or wrongly, individuals are largely left responsible for managing their own CVD risks. By taking proactive measures such as booking regular health check-ups and making lifestyle changes, together the population can help reverse the worsening statistics on early CVD deaths.

Also featured in: BUSINESS INSIDER


Heart DISEASES

MEDTECH

Share:

Recommended

wegovy-vs-ozempic-which-is-the-better-choice-for-weight-loss-post-image

Wegovy vs. Ozempic: Which is the Better Choice for Weight Loss?

In recent years, there has been a significant rise in demand for injectable weight-loss treatments in the UK, as more individuals seek effective solutions for managing obesity and its related health conditions. Two of the most popular options are Wegovy and Ozempic, both of which are semaglutide-based medications. Semaglutide, the active ingredient in both drugs, works by mimicking a hormone that regulates appetite, helping users feel fuller for longer and ultimately aiding in weight reduction.

Read the article

icon
understanding-liver-function-tests-what-are-alt-ast-and-total-bilirubin-post-image

Understanding Liver Function Tests: What Are ALT, AST, and Total Bilirubin?

Have you ever gone for a routine medical check-up and been told you need a liver function test? Suddenly, you're faced with acronyms like ALT, AST, and Total Bilirubin that sound more like alphabet soup than something related to your health. Don't worry—you're not alone! Many people are unfamiliar with these terms and what they mean for their well-being.

Your liver is a vital organ that performs over 500 essential functions every day. It helps detoxify your blood, aids in digestion, stores energy, and much more. Keeping your liver healthy is crucial, and understanding liver function tests can empower you to take charge of your health.

In this article, we'll explore what ALT, AST, and Total Bilirubin are, why they're important, and how they can affect your health. We'll break down these complex topics into simple, easy-to-understand language. By the end, you'll have a clear understanding of these liver function tests and why they matter.

Read the article

icon
combining-wegovy-and-mounjaro-with-personalised-plans-for-maximum-weight-loss-successcombining-wegovy-and-mounjaro-with-personalised-plans-for-maximum-weight-loss-success-post-image

Achieve Weight Loss Goals: Wegovy, Mounjaro, and Personalized Plans

Wegovy and Mounjaro have emerged as two of the most effective medications for weight loss. Both injectable drugs belong to the class of GLP-1 receptor agonists, which help manage appetite and control blood sugar levels. Wegovy, which contains semaglutide, is specifically designed for chronic weight management. It works by mimicking the effects of a natural hormone that regulates appetite, helping users feel full for longer and consume fewer calories. Mounjaro, on the other hand, goes a step further. It contains tirzepatide, which not only activates GLP-1 receptors but also targets GIP receptors, making it even more effective for some individuals by further boosting feelings of satiety and promoting weight loss.

Read the article

icon